Product Launch: Amitzo® - Temozolomide 100 mg Lyophilized Powder for Injection

At NanoAlvand, we’re proud to introduce Amitzo®, Temozolomide 100 mg powder for solution, our latest advancement in the oncology portfolio. This launch marks a significant expansion of our existing capsule dosage forms, offering greater flexibility in treatment administration and addressing a broader range of clinical needs.

Manufacturing lyophilized powder, especially at relatively large volumes, requires dedicated knowledge, advanced process control, and specialized infrastructure. At NanoAlvand, we’ve built the expertise to meet this complexity with confidence and care.

Quoted from the FDA label of Temodar® (09/2023):
"Temozolomide is an alkylating drug indicated for the treatment of adults with:
• Newly diagnosed glioblastoma, concomitantly with radiotherapy and then as maintenance treatment
• Anaplastic astrocytoma, including:
– Adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma
– Treatment of adults with refractory anaplastic astrocytoma"

We continue to uphold our mission of delivering high-quality, high-tech solutions for hazardous molecules—safely and reliably.
Because our HOPE shapes the future.